[1]
M. Zhuang, “Recurrence patterns in patients with advanced non-small cell lung cancer who have received epidermal growth factor receptor tyrosine kinase inhibitors”, Eur J Oncol Env Hea, vol. 21, no. 3, pp. 169–173, Dec. 2016, Accessed: Feb. 23, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4475